RESUMEN
L-arginine, as an essential substance of the immune system, plays a vital role in innate immunity. MiR155, a multi-functional microRNA, has gained importance as a regulator of homeostasis in immune cells. However, the immunoregulatory mechanism between L-arginine and miR155 in bacterial infections is unknown. Here, we investigated the potential role of miR155 in inflammation and the molecular regulatory mechanisms of L-arginine in Streptococcus uberis (S. uberis) infections. And we observed that miR155 was up-regulated after infection, accompanying the depletion of L-arginine, leading to metabolic disorders of amino acids and severe tissue damage. Mechanically, the upregulated miR155 mediated by the p65 protein played a pro-inflammatory role by suppressing the suppressor of cytokine signaling 6 (SOCS6)-mediated p65 ubiquitination and degradation. This culminated in a violently inflammatory response and tissue damage. Interestingly, a significant anti-inflammatory effect was revealed in L-arginine supplementation by reducing miR155 production via inhibiting p65. This work firstly uncovers the pro-inflammatory role of miR155 and an anti-inflammatory mechanism of L-arginine in S.uberis infection with a mouse mastitis model. Collectively, we provide new insights and strategies for the prevention and control of this important pathogen, which is of great significance for ensuring human food health and safety.
Asunto(s)
Arginina , Mastitis , MicroARNs , Infecciones Estreptocócicas , Animales , Femenino , Humanos , Ratones , Arginina/metabolismo , Inflamación/metabolismo , MicroARNs/genética , Infecciones Estreptocócicas/metabolismo , Streptococcus/fisiología , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Mastitis/inmunología , Mastitis/metabolismoRESUMEN
Cystathionine-ß-synthase (CBS) catalyzes the first step of the transsulfuration pathway. The role of host-derived CBS in Staphylococcus aureus (S. aureus)-induced udder infection remains elusive. Herein, we report that S. aureus infection enhances the expression of CBS in mammary epithelial cells in vitro and in vivo. A negative correlation is present between the expression of CBS and inflammation after employing a pharmacological inhibitor/agonist of CBS. In addition, CBS achieves a fine balance between eliciting sufficient protective innate immunity and preventing excessive damage to cells and tissues preserving the integrity of the blood-milk barrier (BMB). CBS/H2S reduces bacterial load by promoting the generation of antibacterial substances (ROS, RNS) and inhibiting apoptosis, as opposed to relying solely on intense inflammatory reactions. Conversely, H2S donor alleviate inflammation via S-sulfhydrating HuR. Finally, CBS/H2S promotes the expression of Abcb1b, which in turn strengthens the integrity of the BMB. The study described herein demonstrates the importance of CBS in regulating the mammary immune response to S. aureus. Increased CBS in udder tissue modulates excessive inflammation, which suggests a novel target for drug development in the battle against S. aureus and other infections.
Asunto(s)
Cistationina betasintasa , Sulfuro de Hidrógeno , Animales , Humanos , Cistationina betasintasa/genética , Cistationina betasintasa/metabolismo , Staphylococcus aureus/metabolismo , Cistationina , Glándulas Mamarias Animales/metabolismo , Inflamación , Sulfuro de Hidrógeno/metabolismoRESUMEN
Mastitis is a common disease of dairy cows characterized by infiltration of leukocytes, especially neutrophils, resulting in increased permeability of the blood-milk barrier (BMB). Taurine, a functional nutrient, has been shown to have anti-inflammatory and antioxidant effects. Here, we investigated the regulatory effects and mechanisms of taurine on the complex immune network of the mammary gland in Streptococcus uberis (S. uberis) infection. We found that taurine had no direct effect on CXCL2-mediated neutrophil chemotaxis. However, it inhibited MAPK and NF-κB signalings by modulating the activity of TAK1 downstream of TLR2, thereby reducing CXCL2 expression in macrophages to reduce neutrophil recruitment in S. uberis infection. Further, the AMPK/Nrf2 signaling pathway was activated by taurine to help mitigate oxidative damage, apoptosis and disruption of tight junctions in mammary epithelial cells caused by hypochlorous acid, a strong oxidant produced by neutrophils, thus protecting the integrity of the mammary epithelial barrier. Taurine protects the BMB from damage caused by neutrophils via blocking the macrophage-CXCL2-neutrophil signaling axis and increasing the antioxidant capacity of mammary epithelial cells.
Asunto(s)
Mastitis Bovina , Infecciones Estreptocócicas , Femenino , Animales , Bovinos , Humanos , Infiltración Neutrófila , Streptococcus , Mastitis Bovina/tratamiento farmacológico , Glándulas Mamarias AnimalesRESUMEN
The emergence of TMexCD1-TOprJ1, a novel transferable resistance-nodulation-division (RND)-type efflux pump conferring resistance to tigecycline, is now a serious public health issue in the world. Here, we found that melatonin synergistically enhanced the antibacterial efficacy of tigecycline against tmexCD1-toprJ1-positive Klebsiella pneumoniae by disrupting the proton driving force and efflux function to promote the accumulation of tigecycline into cells, damaging cell membrane integrity and causing the leakage of cell contents. The synergistic effect was further validated by a murine thigh infection model. The results revealed that the melatonin/tigecycline combination is a potential therapy to combat resistant bacteria carrying the tmexCD1-toprJ1 gene.
Asunto(s)
Infecciones por Klebsiella , Melatonina , Animales , Ratones , Tigeciclina/farmacología , Melatonina/farmacología , Melatonina/metabolismo , Minociclina/farmacología , Infecciones por Klebsiella/tratamiento farmacológico , Infecciones por Klebsiella/microbiología , Farmacorresistencia Bacteriana/genética , Proteínas de Transporte de Membrana/genética , Antibacterianos/uso terapéutico , Adyuvantes Inmunológicos , Adyuvantes Farmacéuticos , Pruebas de Sensibilidad Microbiana , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/metabolismoRESUMEN
OBJECTIVE: Tigecycline is one of the last-resort treatments against multidrug-resistant (MDR) Gram-negative bacteria. Recently, a novel efflux pump gene cluster tmexCD1-toprJ1 has been identified to reduce the antibacterial activity of tigecycline. However, the epidemiological feature and the horizontal transfer of this cluster have not been thoroughly studied in chicken-origin strains. METHODS AND RESULTS: Here, we found that the tmexCD1-toprJ1 gene cluster was present in 32.7% (16/49) of tigecycline-resistant Klebsiella pneumoniae (K. pneumoniae) isolates in a chicken farm. All the strains showed MDR phenotype, and the efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine (NMP) synergized the activity of tigecycline to the tmexCD1-toprJ1-carrying strains by 8- to 128-fold. The S1 nuclease-pulsed field gel electrophoresis (S1-PFGE), and Southern blotting revealed that all the tmexCD1-toprJ1 gene clusters were located on plasmids with various sizes and could be transferred among strains by conjugation and transformation. Furthermore, the tmexCD1-toprJ1-carrying plasmid could have a fitness cost in recipient strains. Sixteen isolates belonged to two different sequence types (ST3332 and ST37), and they were classified into two distinct lineages. Importantly, one plasmid was found to co-harbour tmexCD1-toprJ1 and mcr-8.5, which may pose a potential threat to public health. CONCLUSION: This study demonstrates the clonal dissemination in tmexCD1-toprJ1-carrying K. pneumoniae strains in the chicken farm.
Asunto(s)
Infecciones por Klebsiella , Klebsiella pneumoniae , Animales , Pollos , Células Clonales , Granjas , Infecciones por Klebsiella/microbiología , Infecciones por Klebsiella/veterinaria , Pruebas de Sensibilidad Microbiana , Tigeciclina , beta-Lactamasas/genéticaRESUMEN
Plasmid-mediated fosfomycin determinants is a global public health concern due to the increasing dissemination of fosfomycin resistance and limited clinical treatment options. Information about the fosfomycin resistant and molecular genetic among Enterococcus spp. is still lacking. In this study, we found the first plasmid-medieted fosB in Enterococcus faecalis from pigs, and all the fosfomycin resistant Enterococcus spp. (FRE) isolates were multi-drug resistant. S1-PFGE, Southern blot and conjugation experiments indicated that the fosB gene located on ~54.7 kb transferable plasmids. Relative competition assay confirmed that the fosB-carrying plasmid impaired fitness in recipient E. faecalis JH2-2. Illumina and the MinION sequencing data revealed that both E. faecalis ES-1 and ES-2 isolates belonged to novel ST (ST964), and had 71 SNPs difference. WGS showed that the genetic environments of fosB were diverse among different species, and the linezolid resistance gene optrA was found in the fosB-carrying strains. To summarize, for the first time, we reported plasmid-mediated fosB in E. faecalis from pigs. And, the co-occurrence of fosB and optrA pose a serious threat to public health.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple , Enterococcus faecalis/clasificación , Fosfomicina/farmacología , Plásmidos/genética , Porcinos/microbiología , Animales , Proteínas Bacterianas/genética , Mapeo Cromosómico , Enterococcus faecalis/genética , Aptitud Genética , Secuenciación de Nucleótidos de Alto Rendimiento , Pruebas de Sensibilidad Microbiana , Filogenia , Análisis de Secuencia de ADNRESUMEN
Among the 10 reported mcr genes, mcr-9 was first identified in Salmonella enterica serotype Typhimurium, which is a leading cause of foodborne illness worldwide. However, information about the prevalence and genetic features of mcr-9 is still lacking, especially among food samples. This study reports the presence of mcr-9 in raw milk samples from China; the prevalence rate was low (0.83%, 1/120). mcr-9 was located on a transferable plasmid, and was stable in wild-type S. enterica. However, it had a biological fitness cost when transferred to an Escherichia coli recipient. Whole-genome sequencing revealed that mcr-9 was located on the IncHI2A-type plasmid, and was surrounded by IS903B and IS26 in its flanking regions. The mcr-9-carrying S. enterica 19SE belonged to ST26 and had a multi-drug-resistant phenotype. It was confirmed that mcr-9 did not mediate colistin resistance in this study, indicating that its transfer may not facilitate the dissemination of colistin resistance.